The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((4-(4-Chloro-3-(trifluoromethyl)phenoxy)-3,5-difluorobenzyl)-oxy)-6-(cyclopropyl(methyl)amino)-1-methylpyrimidin-2(1H)-one ID: ALA3794025
Chembl Id: CHEMBL3794025
PubChem CID: 121448402
Max Phase: Preclinical
Molecular Formula: C23H19ClF5N3O3
Molecular Weight: 515.87
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(c1cc(OCc2cc(F)c(Oc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)nc(=O)n1C)C1CC1
Standard InChI: InChI=1S/C23H19ClF5N3O3/c1-31(13-3-4-13)20-10-19(30-22(33)32(20)2)34-11-12-7-17(25)21(18(26)8-12)35-14-5-6-16(24)15(9-14)23(27,28)29/h5-10,13H,3-4,11H2,1-2H3
Standard InChI Key: XBEMBJJFOOIYGP-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.87Molecular Weight (Monoisotopic): 515.1035AlogP: 5.70#Rotatable Bonds: 7Polar Surface Area: 56.59Molecular Species: NEUTRALHBA: 6HBD: 0#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2CX Acidic pKa: CX Basic pKa: 0.99CX LogP: 5.62CX LogD: 5.62Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -1.23
References 1. Chen X, Wang K, Xu W, Ma Q, Chen M, Du L, Mo M, Wang Y, Shen J.. (2016) Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema., 59 (6): [PMID:26927682 ] [10.1021/acs.jmedchem.5b01930 ]